机读格式显示(MARC)
- 000 03180cam a2200457 i 4500
- 008 200223s2020 nyua b 001 0 eng d
- 020 __ |a 9780197514993 |q hardcover : |c CNY209.31
- 020 __ |z 9780197515020 |q electronic book
- 020 __ |z 0197515029 |q electronic book
- 020 __ |z 9780197515006 |q electronic book
- 020 __ |z 0197515002 |q electronic book
- 020 __ |z 9780197515013 |q electronic publication
- 020 __ |z 0197515010 |q electronic publication
- 040 __ |a DLC |b eng |c DLC |e rda |d OCLCO |d OCLCQ |d OCLCF |d N$T |d YDX
- 050 04 |a RA401.A1 |b H37 2020
- 100 1_ |a Hassoun, Nicole, |e author.
- 245 10 |a Global health impact : |b extending access to essential medicines / |c Nicole Hassoun.
- 264 _1 |a New York, NY : |b Oxford University Press, |c [2020]
- 300 __ |a xv, 301 pages : |b illustrations ; |c 17 cm
- 336 __ |a text |b txt |2 rdacontent
- 337 __ |a unmediated |b n |2 rdamedia
- 338 __ |a volume |b nc |2 rdacarrier
- 504 __ |a Includes bibliographical references and index.
- 505 0_ |a Human rights and access to essential medicines -- The human right to health and the virtue of creative resolve -- Promoting global health : the case for a Global Health Impact labelling and licensing -- Individual responsibility for promoting global health : the case for a new kind of socially conscious consumption -- Consumption and social change : the case of Global Health Impact certification -- Beyond experimental political philosophy : evaluating Global Health Impact certification -- Conclusion: Beyond Global Health Impact labelling, licensing, and investment : advancing public health.
- 520 __ |a "Every year 9 million people are diagnosed with tuberculosis, every day more than 13,400 people are infected with AIDs, every 30 seconds malaria kills a child. Many people suffer and die young because they cannot access essential medicines. This book argues that people have a right to access these medicines and proposes some new Global Health Impact labelling, investment, and licensing strategies that encourage pharmaceutical companies to improve global health (global-health-impact.org/new). The idea is to rate these companies based on their medicines' impacts. Highly rated companies will get a Global Health Impact label to use on their products. Socially responsible investment companies and universities might also take the ratings into account in making investment or licensing decisions. After arguing that people do have a right to access essential medicines, this book explores this proposal, its philosophical justification, and its prospects for success"-- |c Provided by publisher.
- 610 20 |a Global Health Impact (Organization : Binghamton, N.Y.)
- 650 _0 |a Drug accessibility.
- 650 _0 |a Medical care, Cost of.
- 650 _0 |a Drugs |x Marketing.
- 650 _0 |a Social responsibility of business.
- 650 _0 |a Consumption (Economics) |x Moral and ethical aspects.
- 650 _0 |a Pharmaceutical industry |x Social aspects.
- 650 _0 |a Right to health.